GO
Loading...

Executive Decision: Daniel Junius, IMGN

Tuesday, 26 Feb 2013 | 6:45 PM ET

Biotech Immunogen showed signs of life today after getting FDA approval of a new breast cancer treatment. Cramer talks to CEO Daniel Junius about the progress of the drug and when patients will see it in doctor's offices, as well as what it means to the company.